Organisation and units
The Medicines Evaluation Board (MEB) assesses and monitors the efficacy, risks and quality of human and veterinary medicines, and the safety of novel foods for human consumption.
- Executive Management
- Science Programme
- Pharmacotherapeutic Groups
- Pharmacology, Toxicology and Kinetics
- Regulatory Information Centre
- Veterinary Medicinal Products
- Botanicals and Novel Foods
- Human Resource Management and Training
- Policy, Regulatory and International Affairs
- Finance, Quality and Control
- Technical Services
- Programme Bureau Operational Management
- Management Support / Facility Services
- Mandated and authorised officers
- Mandated and authorised officers of the Veterinary Medicinal Products Unit
The members of the Board are supported in their work by more than 300 employees of the Medicines Evaluation Board Agency (MEB Agency). As part of the Ministry of Health, Welfare and Sport (VWS) the Agency is responsible for preparing and implementing decisions by the Board and for coordinating pharmacovigilance in the Netherlands.
The Agency also assesses veterinary medicinal products via the Veterinary Medicinal Products Unit and the assessment of novel foods via the Novel Foods Unit. However, the MEB is not responsible for the decision-making and authorisation of veterinary medicinal products and novel foods. The Veterinary Medicinal Products Unit prepares the decision-making of the Veterinary Medicines Board. This Board advises the Minister of Economic Affairs, who is responsible for policy and politics.
In the Netherlands the Ministry of Health, Welfare and Sport (VWS) is the competent authority for assessment of novel foods. The minister asks the Novel Foods Unit of the MEB for a scientific assessment of consumer safety.